Creating Hope Reauthorization Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Creating Hope Reauthorization Act of 2024 is a legislative proposal introduced in the House during the 118th Congress. The bill focuses on health policy, specifically aiming to reauthorize provisions related to the Creating Hope Act, which typically involves incentives for developing treatments for rare pediatric diseases. As of the latest update, the bill was referred to the Subcommittee on Health but has since failed or expired without further legislative action. No official summary or full text is available to provide detailed provisions or changes proposed in this reauthorization.
This bill sought to continue or renew existing health-related incentives for rare pediatric disease treatments but did not advance beyond subcommittee referral and ultimately expired.
- The bill is part of the 118th Congress and was introduced in the House of Representatives.
- It pertains to health policy, likely focusing on rare pediatric diseases based on the title.
- The bill was referred to the Subcommittee on Health on February 16, 2024, but did not progress further and is now failed or expired.
['Patients, particularly children, affected by rare diseases', 'Pharmaceutical and biotechnology companies developing treatments for rare pediatric diseases', 'Health agencies involved in overseeing rare disease treatment programs']
['Lack of detailed legislative text and summary limits understanding of specific provisions and funding mechanisms', 'Failure to advance past subcommittee may reflect challenges in garnering sufficient support or addressing policy complexities', 'Potential tradeoffs in budget allocation or regulatory oversight remain unclear due to missing information']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance beyond this stage and is classified as failed or expired. The Creating Hope Act has been previously enacted to encourage development of treatments for rare pediatric diseases, and this bill appears to be an attempt to reauthorize or extend those provisions.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Without reauthorization, incentives for developing treatments for rare pediatric diseases may lapse, potentially slowing innovation in this area.', 'Health agencies may face uncertainty in program continuity related to rare disease treatment incentives.', 'Pharmaceutical companies might adjust research priorities based on the absence of renewed legislative support.']
The lack of available full text and official summary restricts transparency and public understanding of the bill's specific provisions and potential impacts. The bill's failure to advance beyond subcommittee referral highlights the importance of tracking legislative progress to assess policy developments accurately. Future transparency could be improved by ensuring timely publication of bill texts and summaries.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.